Stephen Jones
Psychiatric/Mental Health · Fayetteville, NCNPI 1720322688
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,644 of the $15,587 with a category attached, or 74.7%. 30 manufacturers reported payments, led by AbbVie at 31.9% of the total. Reporting peaked in 2023 at $6,510 and has fallen 70.4% since, to $1,928 in 2025. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 584 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$950
- Neuronetics, Inc.$751
- Teva Pharmaceuticals USA, Inc.$626
- plus $5K from 24 others
What the payments were for
- Speaking & faculty fees$3,57523%
- Travel & lodging$2992%
- Food & beverage$11,64475%
- Education$690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 95 | $4,973 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 114 | $1,912 |
| Johnson & Johnson(2 entities) | 52 | $1,366 |
| Alkermes, Inc. | 36 | $950 |
| Neuronetics, Inc. | 2 | $751 |
| Teva Pharmaceuticals USA, Inc. | 17 | $626 |
| Otsuka America Pharmaceutical, Inc. | 31 | $597 |
| Supernus Pharmaceuticals, Inc. | 34 | $499 |
| Sunovion Pharmaceuticals Inc. | 31 | $496 |
| Corium, LLC | 29 | $424 |
| Tris Pharma Inc | 20 | $348 |
| Vanda Pharmaceuticals Inc. | 12 | $328 |
| Noven Therapeutics, LLC | 22 | $312 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $285 |
| Lundbeck LLC | 17 | $267 |
| E.r. Squibb & Sons, L.L.C. | 6 | $230 |
| Neurocrine Biosciences, Inc. | 4 | $206 |
| Bausch Health US, LLC | 11 | $201 |
| Axsome Therapeutics, Inc. | 4 | $149 |
| Validus Pharmaceuticals LLC | 1 | $133 |
| Ironshore Pharmaceuticals Inc. | 5 | $107 |
| Idorsia Pharmaceuticals US Inc | 6 | $92 |
| Collegium Pharmaceutical, Inc. | 4 | $89 |
| Almatica Pharma LLC | 4 | $85 |
| Eisai Inc. | 4 | $67 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Neos Therapeutics, LP | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Merck | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,575
- NEUROSTAR TMS THERAPY SYSTEM$751
- ARISTADA$400
- AUSTEDO$375
- SPRAVATO$362
- CAPLYTA$357
- COBENFY$135
- Equetro$133
- INGREZZA$125
- REXULTI$125
- Fanapt$125
- Dyanavel XR$120
- Quillivant$120
- Quillichew ER$120
- ARISTADA INITIO$100
How this compares
$15,587 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 19 | $26,217 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $406 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $286 |
| Lithium Carbonate | 13 | $130 |
| Risperidone | 14 | $114 |
| Trazodone Hcl | 12 | $61 |
| Alprazolam | 19 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $4,973 | $26,21719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Fayetteville
- Ronald PattersonFayetteville$25K
- Robert PennebakerFayetteville$10K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.